News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
772,648 Results
Type
Article (75780)
Company Profile (380)
Press Release (696488)
Multimedia
Podcasts (117)
Webinars (14)
Section
Business (214061)
Career Advice (3104)
Deals (37051)
Drug Delivery (127)
Drug Development (88095)
Employer Resources (175)
FDA (17851)
Job Trends (16120)
News (368867)
Policy (37248)
Tag
Academia (2944)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (54841)
ALS (99)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (156)
Approvals (17818)
Artificial intelligence (300)
Autoimmune disease (27)
Automation (15)
Bankruptcy (379)
Best Places to Work (12187)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (264)
Bladder cancer (83)
Brain cancer (32)
Breast cancer (299)
Cancer (2415)
Cardiovascular disease (202)
Career advice (2622)
Career pathing (34)
CAR-T (171)
Cell therapy (484)
Cervical cancer (21)
Clinical research (71044)
Collaboration (906)
Company closure (1)
Compensation (528)
Complete response letters (30)
COVID-19 (2840)
CRISPR (46)
C-suite (259)
Cystic fibrosis (107)
Data (2262)
Decentralized trials (2)
Denatured (43)
Depression (56)
Diabetes (294)
Diagnostics (6666)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (141)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (85479)
Editorial (45)
Employer branding (22)
Employer resources (154)
Events (116544)
Executive appointments (769)
FDA (19173)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (809)
Gene editing (116)
Generative AI (30)
Gene therapy (350)
GLP-1 (846)
Government (4870)
Grass and pollen (6)
Guidances (67)
Healthcare (19999)
Huntington's disease (23)
IgA nephropathy (31)
Immunology and inflammation (143)
Indications (30)
Infectious disease (2999)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (579)
IPO (17038)
IRA (51)
Job creations (4394)
Job search strategy (2180)
Kidney cancer (11)
Labor market (33)
Layoffs (538)
Leadership (24)
Legal (8992)
Liver cancer (80)
Lung cancer (344)
Lymphoma (159)
Machine learning (7)
Management (60)
Manufacturing (343)
MASH (74)
Medical device (14059)
Medtech (14064)
Mergers & acquisitions (20566)
Metabolic disorders (783)
Multiple sclerosis (86)
NASH (22)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2104)
NextGen: Class of 2025 (7178)
Non-profit (4923)
Now hiring (30)
Obesity (422)
Opinion (273)
Ovarian cancer (77)
Pain (99)
Pancreatic cancer (85)
Parkinson's disease (161)
Partnered (23)
Patents (250)
Patient recruitment (115)
Peanut (51)
People (61269)
Pharmaceutical (91)
Pharmacy benefit managers (21)
Phase I (21977)
Phase II (30913)
Phase III (23339)
Pipeline (1251)
Policy (166)
Postmarket research (3312)
Preclinical (9863)
Press Release (72)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (426)
Real estate (6599)
Recruiting (71)
Regulatory (25692)
Reports (37)
Research institute (2637)
Resumes & cover letters (488)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (142)
Series B (91)
Service/supplier (16)
Sickle cell disease (56)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (3997)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (44)
The Weekly (72)
Vaccines (794)
Venture capitalists (43)
Weight loss (302)
Women's health (39)
Worklife (20)
Date
Today (4)
Last 7 days (922)
Last 30 days (2647)
Last 365 days (34436)
2025 (11428)
2024 (37126)
2023 (41862)
2022 (53143)
2021 (57720)
2020 (56420)
2019 (49735)
2018 (37813)
2017 (35708)
2016 (35769)
2015 (41702)
2014 (35537)
2013 (31923)
2012 (33267)
2011 (33517)
2010 (32568)
Location
Africa (1105)
Alabama (60)
Alaska (6)
Arizona (217)
Arkansas (14)
Asia (46840)
Australia (8093)
California (6271)
Canada (2049)
China (560)
Colorado (275)
Connecticut (296)
Delaware (154)
Europe (106156)
Florida (934)
Georgia (210)
Idaho (58)
Illinois (586)
India (30)
Indiana (318)
Iowa (10)
Japan (169)
Kansas (109)
Kentucky (26)
Louisiana (13)
Maine (66)
Maryland (953)
Massachusetts (4787)
Michigan (243)
Minnesota (408)
Mississippi (2)
Missouri (89)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (70)
New Jersey (1779)
New Mexico (31)
New York (1803)
North Carolina (1078)
North Dakota (9)
Northern California (2702)
Ohio (214)
Oklahoma (15)
Oregon (37)
Pennsylvania (1381)
Puerto Rico (13)
Rhode Island (32)
South America (1429)
South Carolina (24)
South Dakota (1)
Southern California (2346)
Tennessee (102)
Texas (928)
United States (24038)
Utah (188)
Virginia (164)
Washington D.C. (69)
Washington State (584)
West Virginia (3)
Wisconsin (65)
772,648 Results for "centre for drug research and development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer
April 29, 2025
·
3 min read
Webinar: AI, Regulation and the Law: Shaping the Future of Drug Development
In this discussion, our guests explore how recent regulatory changes are shaping the future of AI in drug development in the US market. Watch now.
April 23, 2025
·
1 min read
·
BioSpace Insights
IN PARTNERSHIP WITH SMARTLABS
How Modern Vivarium Services Are Revolutionizing Drug Development
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
March 24, 2025
·
7 min read
·
BioSpace Insights
Opinion
AI Enables Companies to Break From the Herd in Drug Development
Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI could change that.
April 7, 2025
·
6 min read
·
Ruth Gross
Press Releases
Kanvas Bio Publishes New Research on its Novel Spectral Imaging Platform, a Transformative Tool for Microbiome Drug Discovery and Development
April 2, 2025
·
5 min read
Press Releases
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025
·
5 min read
Press Releases
Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit
February 25, 2025
·
6 min read
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
Algernon Pharmaceuticals Inc. is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke study data at the Interdisciplinary Conference on Psychedelic Research being held June 6-8, 2024.
April 24, 2024
·
7 min read
Drug Development
Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug Development Announce First Patient Dosed in ALETA-001 Phase 1/2 Clinical Trial in Patients with Relapsed/Refractory B-Cell Malignancies
Aleta Biotherapeutics, a clinical stage, immuno-oncology company with a CAR T-Cell Engager platform that enables cell cancer therapies to work more effectively, and Cancer Research UK’s Centre for Drug Development, announce the first patient was dosed in a Phase 1/2 clinical trial.
February 21, 2024
·
5 min read
Press Releases
Nanostics Receives CPSA Accreditation for its Newly Relocated Clinical Laboratory at the Biotechnology Business Development Centre in Edmonton
April 16, 2025
·
4 min read
1 of 77,265
Next
